CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 161 filers reported holding CYTOKINETICS INC in Q2 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $10,257,000 | +16.5% | 225,032 | -8.6% | 5.44% | +2.9% |
Q3 2021 | $8,804,000 | +19.5% | 246,336 | -27.6% | 5.29% | +11.8% |
Q3 2020 | $7,366,000 | +51.7% | 340,253 | +65.1% | 4.74% | +27.3% |
Q2 2020 | $4,857,000 | +101.7% | 206,086 | +0.9% | 3.72% | +41.3% |
Q1 2020 | $2,408,000 | +166.4% | 204,251 | +139.8% | 2.63% | +62.6% |
Q4 2019 | $904,000 | – | 85,172 | – | 1.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |